Life Sciences Portfolio Management Strategy

Why do you need a level zero assessment?

Take a step back and identify optimal path forward

Effective portfolio management ensures life sciences organizations to improve patient outcomes, while maintaining financial and operational stability.

Systematic processes in place to oversee and optimize assets, projects and investments means achieving strategic objectives and maximizing the pipeline value.

Our level zero assessment model

Level zero assessment results in road mapping focus areas, provide depth of knowledge and optimize delivery-Guided by advisory services and delivered by technical services.

Our services

With over a decade of industry experience we bring you customized consulting services for small, medium and enterprise life sciences organizations. i2e is proficient in developing end-to-end digital PPM road maps for organizations at any level of digital maturity. Our expertise in leading PPM tools such as Planisware, Planview and Microsoft Project Online enable us to analyze the business need and propose the right fit.

PPM consulting

With over a decade of industry experience we bring you customized consulting services for small, medium and enterprise life sciences organizations. i2e is proficient in developing end-to-end digital PPM road maps for organizations at any level of digital maturity. Our expertise in leading PPM tools such as Planisware, Planview and Microsoft Project Online enable us to analyze the business need and propose the right fit.

Leading life sciences organizations towards data-backed decisions, our PPM analytics services are designed to solve data siloes and disparities in project management. We deployed custom PPM analytics solutions across the drug development cycle which enabled decision makers to have a 360-degree view of the entire portfolio.

PPM analytics

Leading life sciences organizations towards data-backed decisions, our PPM analytics services are designed to solve data siloes and disparities in project management. We deployed custom PPM analytics solutions across the drug development cycle which enabled decision makers to have a 360-degree view of the entire portfolio.

What does a successful level zero assessment offer?

Secure future business growth

Streamlining the innovation pipeline to prioritize high-growth opportunities is essential for an assured future growth potential. Visualizing the path towards integrated insights to guide better resource management and portfolio investment decisions leads to confident data-backed decisions aligned with the strategic objectives.

Readiness assessment

Portfolio optimization is a continuous improvement process. As the organization matures, the need to improve processes also arises. Providing an in-depth analysis of past, current and optimal future state analysis with roadmap can help in aligning processes, and data with the strategic goals and objectives. It will also assist in Prioritizing investments to offer a more unified view of the portfolio.

Return on R&D

Life sciences R&D investments are heavy and continue to rise, organizations need to take data-backed smart decisions while choosing to invest in projects. Giving a 360-degree view of the complete PPM processes along with future potential will give a roadmap to achieve decision confidence for the decision makers.

Risk management

While making portfolio decisions, it is imperative to make sure they maximize returns while mitigate the risk of missed opportunities. Having a systematic process to accurately monitor the portfolio performance can help identify potential risks early on and make a clear tradeoff between risks and returns.

Guiding life sciences from pipeline growth to topline growth

Systematic processes in place to oversee and optimize assets, projects and investments means achieving strategic objectives and maximizing the pipeline value.

Our level zero assessment model

PPM consulting

PPM analytics

Let us guide you in aligning investments, optimizing resources, and delivering impactful solutions to advance global health.